Consultancy work to evaluate the all-Wales Suspected Cancer Pathway (SCP) Programme

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-kuma6s-132373-2024-06-13T00:00:00Z",
    "date": "2024-06-13T00:00:00Z",
    "ocid": "ocds-kuma6s-132373",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-43",
            "name": "NHS Wales Shared Services Partnership",
            "identifier": {
                "legalName": "NHS Wales Shared Services Partnership"
            },
            "address": {
                "streetAddress": "2nd Floor Woodland House, Maes-y-Coed Road",
                "locality": "Cardiff",
                "region": "UK",
                "postalCode": "CF14 4TT"
            },
            "contactPoint": {
                "email": "Nia.Miles@wales.nhs.uk",
                "telephone": "+44 2921508271",
                "url": "https://etenderwales.bravosolution.co.uk/home.html"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Regional or local authority",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    },
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    }
                ],
                "url": "http://www.procurement.wales.nhs.uk"
            }
        },
        {
            "id": "org-2",
            "name": "High Court",
            "identifier": {
                "legalName": "High Court"
            },
            "address": {
                "streetAddress": "Royal Courts of Justice, The Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL"
            },
            "contactPoint": {
                "telephone": "+44 2079477501"
            },
            "roles": [
                "reviewBody"
            ]
        },
        {
            "id": "org-26",
            "name": "NHS Wales Shared Services Partnership",
            "identifier": {
                "legalName": "NHS Wales Shared Services Partnership"
            },
            "address": {
                "streetAddress": "4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw",
                "locality": "Cardiff",
                "region": "UK",
                "postalCode": "CF15 7QZ"
            },
            "contactPoint": {
                "name": "Shannon Mason",
                "email": "shannon.mason@wales.nhs.uk",
                "telephone": "+44 1443848585"
            },
            "roles": [
                "buyer",
                "reviewBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    },
                    {
                        "id": "Regional or local authority",
                        "scheme": "TED_CA_TYPE"
                    }
                ],
                "url": "http://www.procurement.wales.nhs.uk"
            }
        },
        {
            "id": "org-53",
            "name": "Carnall Farrar",
            "identifier": {
                "legalName": "Carnall Farrar"
            },
            "address": {
                "streetAddress": "91 Wimpole Street",
                "locality": "London",
                "region": "UK",
                "postalCode": "W1G0EF"
            },
            "contactPoint": {
                "telephone": "+44 2037707536"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "sme"
            }
        },
        {
            "id": "org-3",
            "name": "High Court",
            "identifier": {
                "legalName": "High Court"
            },
            "address": {
                "streetAddress": "Royal Courts of Justice, The Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL"
            },
            "contactPoint": {
                "telephone": "+44 2079477501"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "name": "NHS Wales Shared Services Partnership",
        "id": "org-26"
    },
    "tender": {
        "id": "ocds-kuma6s-132373-tender-142164-CAV-ITT-PROJECT53738",
        "title": "Consultancy work to evaluate the all-Wales Suspected Cancer Pathway (SCP) Programme",
        "description": "NHS Procurement Wales, on behalf of the NHS Executive, Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Suspected Cancer Programme (SCP) programme. The 3-year Suspected Cancer Pathway (SCP) Programme was introduced in April 2021, as a national programme to support NHS organisations to transform their cancer patient pathways through a whole system approach. The programme was intended to provide a platform for innovation across the diagnostic and treatment intervals of the patient pathway by developing a suite of National Optimal Pathways (NOPs). The NOPs are designed to align with the metric of the Suspected Cancer Pathway, and describe the optimal steps, sequence and associated timings along the patient cancer pathway, including all diagnostic steps, investigations and treatments. The SCP programme aims to deliver the vision of the NOPs aligned to the metric of the SCP to achieve better outcomes and experience for cancer patients across Wales. We require a robust and independent assessment of the impact of the SCP programme. The following key programme deliverables were identified: * To review, develop and publish the National Optimal Pathways. * In partnership with cancer Multidisciplinary Teams support the implement of the National Optimal Pathways through a whole-system approach. * Support health boards to improve SCP performance (Point of Suspicion to First Definitive Treatment). * Deliver the programme through a Value Based Health Care approach, to achieve better outcomes and experiences for cancer patients. * Work collaboratively with health boards and stakeholders to share learning from the programme activities. Programme aim and objectives Aim: * To enable effective implementation of the SCP across Wales, through a whole system approach informed by business intelligence data. Objectives: * To support health boards/trust in Wales to implement the SCP performance target (Point of Suspicion to First Definitive Treatment within 62 days) aligned to the best practice principles described by the National Optimal Pathways. * To work in partnership with cancer MDTs to embed the vision of the National Optimal Pathways. To support Health Boards/ Trust to implement data driven service improvements across the National Optimal Pathways",
        "status": "complete",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "79419000",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "NHS Collaborative - Cardiff"
                },
                "deliveryAddresses": [
                    {
                        "region": "UKL22"
                    },
                    {
                        "region": "UKL22"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "value": {
            "amount": 100000,
            "currency": "GBP"
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "mainProcurementCategory": "services",
        "submissionMethod": [
            "electronicSubmission"
        ],
        "submissionMethodDetails": "http://NWSSP.Cardiff.Procurement@wales.nhs.uk",
        "tenderPeriod": {
            "endDate": "2023-07-04T12:00:00Z"
        },
        "awardPeriod": {
            "startDate": "2023-07-04T12:00:00Z"
        },
        "documents": [
            {
                "id": "JUN440702",
                "documentType": "contractNotice",
                "title": "Consultancy work to evaluate the all-Wales Suspected Cancer Pathway (SCP) Programme",
                "description": "NHS Procurement Wales, on behalf of the NHS Executive, Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Suspected Cancer Programme (SCP) programme. The 3-year Suspected Cancer Pathway (SCP) Programme was introduced in April 2021, as a national programme to support NHS organisations to transform their cancer patient pathways through a whole system approach. The programme was intended to provide a platform for innovation across the diagnostic and treatment intervals of the patient pathway by developing a suite of National Optimal Pathways (NOPs). The NOPs are designed to align with the metric of the Suspected Cancer Pathway, and describe the optimal steps, sequence and associated timings along the patient cancer pathway, including all diagnostic steps, investigations and treatments. The SCP programme aims to deliver the vision of the NOPs aligned to the metric of the SCP to achieve better outcomes and experience for cancer patients across Wales. We require a robust and independent assessment of the impact of the SCP programme. The following key programme deliverables were identified: * To review, develop and publish the National Optimal Pathways. * In partnership with cancer Multidisciplinary Teams support the implement of the National Optimal Pathways through a whole-system approach. * Support health boards to improve SCP performance (Point of Suspicion to First Definitive Treatment). * Deliver the programme through a Value Based Health Care approach, to achieve better outcomes and experiences for cancer patients. * Work collaboratively with health boards and stakeholders to share learning from the programme activities. Programme aim and objectives Aim: * To enable effective implementation of the SCP across Wales, through a whole system approach informed by business intelligence data. Objectives: * To support health boards/trust in Wales to implement the SCP performance target (Point of Suspicion to First Definitive Treatment within 62 days) aligned to the best practice principles described by the National Optimal Pathways. * To work in partnership with cancer MDTs to embed the vision of the National Optimal Pathways. To support Health Boards/ Trust to implement data driven service improvements across the National Optimal Pathways",
                "url": "https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=JUN440702",
                "format": "text/html"
            },
            {
                "id": "economic",
                "documentType": "economicSelectionCriteria"
            },
            {
                "id": "technical",
                "documentType": "technicalSelectionCriteria"
            },
            {
                "id": "JUN480883",
                "documentType": "awardNotice",
                "title": "Consultancy work to evaluate the all-Wales Suspected Cancer Pathway (SCP) Programme",
                "description": "NHS Procurement Wales, on behalf of the NHS Executive, Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Suspected Cancer Programme (SCP) programme. The 3-year Suspected Cancer Pathway (SCP) Programme was introduced in April 2021, as a national programme to support NHS organisations to transform their cancer patient pathways through a whole system approach. The programme was intended to provide a platform for innovation across the diagnostic and treatment intervals of the patient pathway by developing a suite of National Optimal Pathways (NOPs). The NOPs are designed to align with the metric of the Suspected Cancer Pathway, and describe the optimal steps, sequence and associated timings along the patient cancer pathway, including all diagnostic steps, investigations and treatments. The SCP programme aims to deliver the vision of the NOPs aligned to the metric of the SCP to achieve better outcomes and experience for cancer patients across Wales. We require a robust and independent assessment of the impact of the SCP programme. The following key programme deliverables were identified: * To review, develop and publish the National Optimal Pathways. * In partnership with cancer Multidisciplinary Teams support the implement of the National Optimal Pathways through a whole-system approach. * Support health boards to improve SCP performance (Point of Suspicion to First Definitive Treatment). * Deliver the programme through a Value Based Health Care approach, to achieve better outcomes and experiences for cancer patients. * Work collaboratively with health boards and stakeholders to share learning from the programme activities. Programme aim and objectives Aim: * To enable effective implementation of the SCP across Wales, through a whole system approach informed by business intelligence data. Objectives: * To support health boards/trust in Wales to implement the SCP performance target (Point of Suspicion to First Definitive Treatment within 62 days) aligned to the best practice principles described by the National Optimal Pathways. * To work in partnership with cancer MDTs to embed the vision of the National Optimal Pathways. To support Health Boards/ Trust to implement data driven service improvements across the National Optimal Pathways",
                "url": "https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=JUN480883",
                "format": "text/html"
            }
        ],
        "lots": [
            {
                "id": "1",
                "description": "NHS Procurement Wales, on behalf of the NHS Executive, Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Suspected Cancer Programme (SCP) programme. The 3-year Suspected Cancer Pathway (SCP) Programme was introduced in April 2021, as a national programme to support NHS organisations to transform their cancer patient pathways through a whole system approach. The programme was intended to provide a platform for innovation across the diagnostic and treatment intervals of the patient pathway by developing a suite of National Optimal Pathways (NOPs). The NOPs are designed to align with the metric of the Suspected Cancer Pathway, and describe the optimal steps, sequence and associated timings along the patient cancer pathway, including all diagnostic steps, investigations and treatments. The SCP programme aims to deliver the vision of the NOPs aligned to the metric of the SCP to achieve better outcomes and experience for cancer patients across Wales. We require a robust and independent assessment of the impact of the SCP programme. The following key programme deliverables were identified: * To review, develop and publish the National Optimal Pathways. * In partnership with cancer Multidisciplinary Teams support the implement of the National Optimal Pathways through a whole-system approach. * Support health boards to improve SCP performance (Point of Suspicion to First Definitive Treatment). * Deliver the programme through a Value Based Health Care approach, to achieve better outcomes and experiences for cancer patients. * Work collaboratively with health boards and stakeholders to share learning from the programme activities. Programme aim and objectives Aim: * To enable effective implementation of the SCP across Wales, through a whole system approach informed by business intelligence data. Objectives: * To support health boards/trust in Wales to implement the SCP performance target (Point of Suspicion to First Definitive Treatment within 62 days) aligned to the best practice principles described by the National Optimal Pathways. * To work in partnership with cancer MDTs to embed the vision of the National Optimal Pathways. To support Health Boards/ Trust to implement data driven service improvements across the National Optimal Pathways",
                "status": "complete",
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 180
                },
                "hasRenewal": false,
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "quality",
                            "name": "Quality",
                            "description": "70%"
                        },
                        {
                            "type": "price",
                            "description": "30%"
                        }
                    ]
                }
            }
        ],
        "bidOpening": {
            "date": "2023-07-04T12:00:00Z"
        },
        "contractTerms": {
            "performanceTerms": "As stated within the ITT"
        },
        "coveredBy": [
            "GPA"
        ],
        "otherRequirements": {
            "requiresStaffNamesAndQualifications": true
        },
        "selectionCriteria": {
            "criteria": [
                {
                    "type": "suitability",
                    "description": "Details can be found within the tender documents. The documents can be obtained from eTender Wales Bravo Solutionas"
                },
                {
                    "type": "technical",
                    "description": "Execution of the service is reserved to a particular profession"
                }
            ]
        },
        "submissionTerms": {
            "languages": [
                "en"
            ]
        },
        "classification": {
            "id": "79419000",
            "scheme": "CPV"
        },
        "hasRecurrence": false,
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        }
    },
    "language": "EN",
    "description": "Please note additional information on this procurement: 1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award contract. 2. Bidders should note that they will be required to enter into terms and conditions of contract as set out in the ITT and that save for matters of clarification or consistency the Contracting Authority will not negotiate the terms. 3. The Contracting Authority will not accept completed ITT's after the stated closing date. 4. All documents to be priced (where applicable) in sterling and all payments made in sterling. 5. All tender costs and liabilities incurred by bidders shall be the sole responsibility of the bidders. 6. In reference to II.1.9 (Variants) to the extent permitted, if at all, in the tender documents. 7. Prospective suppliers should note that NHS Shared Services Partnership - Procurement Services is acting on behalf of Cardiff and Vale ULHB. NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at http://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=65818. NOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at http://www.sell2wales.gov.wales/search/search_switch.aspx?ID=68368 (WA Ref:68368) The Health Board will ensure that this procurement process, which is being undertaken in accordance with the Open Procedure, pursuant to and as defined in the Public Contracts Regulations 2015 (as amended) Light Touch Regime. (WA Ref:142164)",
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.sell2wales.gov.wales/v1?lang=cy/Notice?id=ocds-kuma6s-132373"
        }
    ],
    "noticetype": "OJEU - F3 - Contract Award Notice",
    "awards": [
        {
            "id": "ocds-kuma6s-132373-award-142164-43",
            "suppliers": [
                {
                    "id": "org-53",
                    "name": "Carnall Farrar"
                }
            ],
            "relatedLots": [
                "1"
            ]
        }
    ],
    "contracts": [
        {
            "id": "ocds-kuma6s-132373-award-142164-43",
            "awardID": "ocds-kuma6s-132373-award-142164-43",
            "status": "active",
            "value": {
                "amount": 99920,
                "currency": "GBP"
            },
            "dateSigned": "2023-12-18T00:00:00Z"
        }
    ],
    "relatedProcesses": [
        {
            "id": "1",
            "relationship": [
                "planning"
            ],
            "scheme": "EU-OJ",
            "identifier": "2023/S 000-016823"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "ocds-kuma6s-132373-bidsstatistic-142164-163",
                "measure": "bids",
                "value": 14,
                "relatedLot": "1"
            },
            {
                "id": "ocds-kuma6s-132373-bidsstatistic-142164-164",
                "measure": "smeBids",
                "value": 6,
                "relatedLot": "1"
            },
            {
                "id": "ocds-kuma6s-132373-bidsstatistic-142164-165",
                "measure": "foreignBidsFromEU",
                "value": 0,
                "relatedLot": "1"
            },
            {
                "id": "ocds-kuma6s-132373-bidsstatistic-142164-166",
                "measure": "foreignBidsFromNonEU",
                "value": 0,
                "relatedLot": "1"
            },
            {
                "id": "ocds-kuma6s-132373-bidsstatistic-142164-167",
                "measure": "electronicBids",
                "value": 14,
                "relatedLot": "1"
            }
        ]
    }
}